SNCA and Parkinson disease: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the overtime loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc), the accumulation of α-synuclein (αS)-containing aggregates, and dopamine (DA) deficit in the striatum [1].